Local immune response in cutaneous basal cell carcinoma
- PMID: 28975891
Local immune response in cutaneous basal cell carcinoma
Abstract
BCC is an immunogenic tumor highlighted by the increased risk in immunosuppressed individuals and the frequent occurrence of tumor infiltrating lymphocytes (TILs) in the tumor surroundings. Immunotherapy is evolving as a promising treatment strategy for several cancer types where topical immunostimulators are among the possibilities for superficial BCC. The overall aim of this thesis is to characterize the immunologic response upon BCC as well as characterizing the surrounding tumor stroma. The aim was achieved by the use of a variety of laboratory techniques; immunohistochemistry, immunoflourescence, qRT-PCR and NGS. Tumor microenvironment: T-regs are a subpopulation of the CD4 positive T-cells normally comprising around 5-10% of the peripheral T-cells and up to 20% of the skin resident T-cells. In the healthy individual they are crucial in hindering autoimmune diseases whereas the role in cancer is less advantageous with association to tumor progression for a variety of cancer types. By investigating the presence of T-regs in BCC by immunohistochemistry in study I, it was found that T-regs comprised 45% in mean of the total CD4 positive cells in BCC. The increased T-reg concentration was confirmed with qRT-PCR showing increased Foxp3 expression levels in BCC as well as in the peritumoral skin. In the normal non-UV exposed buttock skin, no Foxp3 expression was found. Hence, T-regs seem to play a role both in BCC but also in the tumor surroundings. Tumor surroundings are essential in terms of the ability for a tumor to grow. Apart from interaction between immune and cancer cells, also crosstalk with cells of the connective tissue such as CAFs is essential. In study II, NGS revealed increased expression of the CAF-markers P4H and PDGFR-β in BCC. Subsequent qRT-PCR confirmed this and also showed increased expression in the peritumoral skin whereas no expression was found in the normal buttock skin. FAP-α expression was seen only within BCC. CAFs are thus highly present within BCC and we further hypothesize that fibroblasts in the peritumoral skin acquire a phenotype intermediate between normal fibroblasts and CAFs in BCC. This intermediate phenotype might be induced by chronic UV-exposure mediated by increased IL6 expression. This corresponds to our findings of highly increased IL6 expression primarily in the peritumoral skin and to previous literature describing CAF-induced tumor-promoting IL6 expression upon UV-exposure in cutaneous SCC. Recruitment of TILs to BCC: mRNA expression levels of the chemokines CCL17, CCL18, CCL22 and CXCL12, involved in T-reg attraction to tumor sites were increased both in tumor and peritumoral skin with lack of expression in the normal skin. Correlation between the chemokines CCL17 and CXCL12 and CAF markers was found by IF establishing a role for CAFs in attracting T-regs to tumor sites. Efficient immunologic anti-tumor response could be provided by clonal expansion of T-cells directed against tumor-antigens. If this was the case, then restricted TCR-repertoire in BCC compared with surrounding skin would be seen. Analysis of the α and β- chain of the TCR was performed showing a high diversity of TCR repertoire in BCC and lack of predominant V(D)J-gene usage, no preferential VJ pairing or specific CDR3 length distribution. Therefore, no support of antigen-driven clone selection was found. This corresponds with lack of obvious anti-tumor skewing towards a Th1, Th2 or Th17 polarization.
Conclusion: To summarize it has been shown, with these studies on the local immune response upon BCC development, that an immunologic response is generated in line with BCC being an immunogenic tumor. This response is not specific, though. Additionally, BCC is capable of generating a protective niche in the microenvironment composed of both T-regs and CAFs breeding local immunosuppression and hindering of adequate anti-tumor response. In a clinical perspective, further research in improving immunotherapy for BCC is promising since an immunological response is present but needs to be reactivated.
Articles published in the Danish Medical Journal are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Similar articles
-
Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.BMC Cancer. 2017 Oct 7;17(1):675. doi: 10.1186/s12885-017-3663-0. BMC Cancer. 2017. PMID: 28987144 Free PMC article.
-
Immunosuppressive Environment in Basal Cell Carcinoma: The Role of Regulatory T Cells.Acta Derm Venereol. 2016 Nov 2;96(7):917-921. doi: 10.2340/00015555-2440. Acta Derm Venereol. 2016. PMID: 27117439
-
High diversity of the T-cell receptor repertoire of tumor-infiltrating lymphocytes in basal cell carcinoma.Exp Dermatol. 2017 May;26(5):454-456. doi: 10.1111/exd.13240. Epub 2017 Jan 19. Exp Dermatol. 2017. PMID: 27714856
-
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression.Int J Mol Sci. 2019 Sep 23;20(19):4719. doi: 10.3390/ijms20194719. Int J Mol Sci. 2019. PMID: 31547627 Free PMC article. Review.
-
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1. Mol Cancer. 2021. PMID: 34635121 Free PMC article. Review.
Cited by
-
Skin Cancer Microenvironment: What We Can Learn from Skin Aging?Int J Mol Sci. 2023 Sep 13;24(18):14043. doi: 10.3390/ijms241814043. Int J Mol Sci. 2023. PMID: 37762344 Free PMC article. Review.
-
Regulatory T Cells but Not Tumour-Infiltrating Lymphocytes Correlate with Tumour Invasion Depth in Basal Cell Carcinoma.Diagnostics (Basel). 2022 Nov 29;12(12):2987. doi: 10.3390/diagnostics12122987. Diagnostics (Basel). 2022. PMID: 36552993 Free PMC article.
-
Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response.Front Med (Lausanne). 2022 Jun 14;9:893063. doi: 10.3389/fmed.2022.893063. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35775005 Free PMC article. Review.
-
Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.Front Med (Lausanne). 2022 Apr 29;9:879500. doi: 10.3389/fmed.2022.879500. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572966 Free PMC article. Review.
-
The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance.Front Mol Biosci. 2022 Apr 26;9:864302. doi: 10.3389/fmolb.2022.864302. eCollection 2022. Front Mol Biosci. 2022. PMID: 35558554 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
